Click here to find the answers to the most frequently asked questions about ACC.17!

Contact the ACC Registration and Housing Center

  • (888) 322-2878
  • (847) 996-5822 (International)
  • M-F, 9:00 a.m. - 6:00 p.m. ET
  • Accreditation

      Statement of Educational Need and Purpose
      Statement of Educational Need and Purpose

    Despite tremendous advances in recent years, cardiovascular disease (CVD) remains the leading cause of death throughout the world. The reasons for this are numerous. While any areas within CVD require further research to improve outcomes, other areas have established best-practice patterns, but struggle with implementation. Cardiologists along with other members of the cardiovascular team are critical in leading the way to address these issues.

    Education is key to improvements in cardiovascular care. ACC.17 will feature innovative educational activities that provide unique opportunities to share important research findings which range from basic and translational science, to population health and clinical practice. ACC.17 will also serve as an ideal setting for review of core CVD topics and provide for face-to-face networking opportunities. This year’s Scientific Session will feature novel ways to implement patient care tools and to disseminate best practices for patients with simple as well as complex CVD. ACC.17 will bring together healthcare professionals from across the country and around the world to learn from one another providing an exceptional sharing experience. This meeting will be inspirational and transformational with direct and demonstrable beneficial effects on the practice of cardiovascular medicine.

    New ideas and research addressing CVD are evolving; ACC.17 will highlight the latest advances and reinforce time-tested tools aimed at preventing and addressing CVD. It remains imperative that cardiovascular professionals have an opportunity for a comprehensive review of evidence-based practices and exposure to state-of-the-art updates, innovative techniques and novel research on the diagnosis and management of cardiovascular disease. ACC.17 is the place for all of this and more.

      Educational Program Goals
      Educational Program Goals
    • To provide a stimulating environment for information sharing, presentation of research, networking and collaboration with a goal of improving cardiovascular disease management for all patients
    • To facilitate translation of cardiovascular science to all members of the heart team resulting in high-quality, patient-centered care
    • To allow for examination and discussion of important contributions and controversies in cardiovascular care
    • To integrate traditional and novel educational techniques to create an interactive and informative learning environment

    Credit Information


    The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The ACCF designates this live activity for a maximum of 33 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    The American College of Cardiology Foundation (ACCF) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    The ACCF designates this educational activity for a maximum of 31.75 CNE contact hours. Requirements for successful completion are attendance in a session in its entirety and completing the evaluation tool.


    EBACContinuing Pharmacy Education

    Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Postgraduate Institute for Medicine designates this continuing education activity for 26 contact hour(s) (CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge

      European Board for Accreditation in Cardiology (EBAC) External CME Credit
      European Board for Accreditation in Cardiology (EBAC) External CME Credit

    EBACThe live activity “ACC.17” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 18 hours of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME) and the European Board for Accreditation in Cardiology (EBAC) have recognized each other’s accreditation systems as substantially equivalent.

      Maintenance of Certification
      Maintenance of Certification

    EBACSuccessful completion of this CME activity enables the participant to earn up to 33 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Learning Objectives

      Acute and Stable Ischemic Heart Disease
      Acute and Stable Ischemic Heart Disease

    As a result of participating in the Acute and Stable Ischemic Heart Disease Pathway sessions, learners will have an improved or reinforced ability to:

    1. Compare and contrast different STEMI systems of care and logistical processes for managing complex patients with ACS
    2. Formulate a differential diagnosis and management strategy for athletes presenting with cardiac disease
    3. Scrutinize the methodology of recent ACS clinical trials and existing gaps in current guidelines to determine the implications and generalizability of findings
    4. Manage a woman through pregnancy, from cardiac risk to cardiac complications, and understand what is needed to create a cardio-obstetrics team
    5. Evaluate the evidence and different perspectives underlying current controversies in ACS management
    6. Describe the pathophysiology of spontaneous coronary artery dissection (SCAD) and its implications for management
    7. Integrate the expertise of a multidisciplinary Heart Team, as well as patient preferences and values, into treatment planning for complex CAD
    8. Incorporate advances in cardiac rehab into clinical practice and adequately counsel post-MI patients
    9. Understand where sex differences exist in cardiovascular medicine and how to tailor management accordingly
    10. Assess and appropriately manage patients with cardiogenic shock or in need of critical care, and recognize when care has become futile
    11. Detect and manage patients with angina in the absence of obstructive coronary artery disease
    12. Risk-stratify and tailor the selection of medical management vs. revascularization for individual patients with ischemia
      Arrhythmias and Clinical EP
      Arrhythmias and Clinical EP

    As a result of participating in the Arrhythmias and Clinical EP Pathway sessions, learners will have an improved or reinforced ability to:

    1. Recognize and interpret salient ECG patterns and integrate into clinical decision-making
    2. Screen and evaluate athletes for heart disease and provide counseling on sports participation to youth with known cardiovascular disease
    3. Integrate findings from family history, ECG, molecular, and genetic testing to assess and mitigate risk of sudden cardiac death
    4. Apply recent evidence and current guideline recommendations to the management of cardiac arrest
    5. Identify patients with heart failure who can benefit from currently available and investigational device-based therapies
    6. Appropriately manage patients with a cardiac implantable device
    7. Appropriately integrate the emerging evidence and options for prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation
    8. Establish an appropriate differential diagnosis and treatment plan for patients with syncope
      Congenital Heart Disease
      Congenital Heart Disease

    As a result of participating in the Congenital Heart Disease (CHD) Pathway sessions, learners will have an improved or reinforced ability to:

    1. Recognize the patient with CHD who should be managed or periodically assessed at a specialized CHD Care Center
    2. Avoid common pitfalls in the management of patients with CHD
    3. Identify contemporary strategies in invasive and noninvasive imaging to effectively evaluate CHD and to minimize radiation risks for patients and the cardiovascular team
    4. Integrate contemporary technologies and non-clinical expertise into surgical planning for CHD
    5. Identify and manage patients at high-risk for premature onset and atypical manifestations of coronary artery disease
    6. Formulate a plan for transitioning youth with CHD from pediatric to adult cardiology care that considers disease status, patient and family preferences, and future needs for cardiovascular services
    7. Describe the role of emerging transcatheter therapies and surgical techniques in the management of CHD
    8. Establish high-functioning teams and participate in local and national quality improvement initiatives to identify critical gaps as well as potential strategies for better care delivery
    9. Understand the structure and applications of multicenter registries, such as IMPACT, to improve patient care in CHD
    10. Utilize the latest understanding of exercise in CHD and pediatric heart disease to enhance patient quality of life
      Heart Failure and Cardiomyopathy
      Heart Failure and Cardiomyopathy

    As a result of participating in the Heart Failure and Cardiomyopathies Pathway sessions, learners will have an improved or reinforced ability to:

    1. Integrate contemporary concepts on pathogenesis into the evaluation and management of patients with heart failure and cardiomyopathy
    2. Offer practical guidance on diet, exercise, social support, and heart failure self-management that is appropriately tailored for diverse patients
    3. Recognize the implications of sleep apnea, diabetes, chronic kidney disease, atrial fibrillation, oncologic therapies and other comorbidities on the management of heart failure
    4. Evaluate the role and indications for ICDs, CRTs, hemodynamic sensors, and other cardiac devices for heart failure management
    5. Identify patients with Stage D heart failure or cardiogenic shock that are appropriate candidates for specific pharmacotherapies, mechanical circulatory support, cardiac transplantation, and/or palliative care
    6. Analyze the evidence on new and established pharmacotherapies for heart failure management
    7. Participate in high-functioning teams and refine system processes to improve care quality and outcomes for patients with heart failure
      Interventional Cardiology
      Interventional Cardiology

    As a result of participating in the Interventional Pathway sessions, learners will have an improved or reinforced ability to:

    1. Monitor and address gaps in quality, appropriateness, reimbursement, and safety in the cardiac catheterization and vascular lab and participate in meaningful public reporting
    2. Determine an appropriate adjunctive and long-term antithrombotic regimen for diverse patients with acute coronary syndrome or undergoing a revascularization procedure
    3. Interpret and integrate findings from adjunctive coronary and endovascular assessment into clinical decision-making
    4. Decide whether and how to revascularize patients who are high-risk or have complex coronary artery disease
    5. Evaluate the evidence from clinical trials describing outcomes, recent advances, and expanded applications of transcatheter aortic valve replacement (TAVR)
    6. Describe key tactics for preventing and managing interventional complications
    7. Appropriately incorporate new and state-of-the-art structural heart and endovascular technologies and techniques into patient care
    8. Work effectively as part of a comprehensive care team to manage patients before, during, and after an interventional procedure
    9. Apply findings from diagnostic imaging to plan treatment, guide intervention, and gauge procedural outcomes
      Noninvasive Imaging
      Noninvasive Imaging

    As a result of participating in the Noninvasive Imaging Pathway sessions, learners will have an improved or reinforced ability to:

    1. Evaluate the pros, cons, and appropriate use of coronary calcium scoring, cardiac CT, and CCTA for assessing CVD risk in asymptomatic patients
    2. Compare the relative strengths, limitations, risks, and costs of noninvasive functional and anatomical tests to evaluate patients with ischemic heart disease
    3. Apply current guidelines on echocardiography to the assessment of chamber size and function and measurement of valvular regurgitation
    4. Utilize findings from noninvasive imaging to clarify the etiology and guide the management of patients with heart failure or cardiomyopathy
    5. Define the key considerations in choosing multimodality imaging to identify patients with aortopathy and monitor patients with known aortic disease
    6. Describe recent innovations and advanced techniques in noninvasive imaging and their potential applications

    As a result of participating in the Prevention Pathway sessions, learners will have an improved or reinforced ability to:

    1. Describe the role of genetics in lipid metabolism, atherosclerotic cardiovascular disease (ASCVD) risk, and lipid management
    2. Integrate evidence-based diagnostic testing, and shared decision-making into ASCVD risk assessment and risk factor management
    3. Apply current evidence base to determine thresholds for hypertension treatment, establish therapeutic goals, and implement system-based processes to achieve timely blood pressure control
    4. Recognize the implications of diabetes on cardiovascular disease and treatment outcomes and tailor management accordingly
    5. Evaluate often conflicting recommendations as well as the underlying evidence on lipid management
    6. Discuss recent clinical trials assessing new therapeutics for prevention and management of ASCVD
    7. Integrate best practices with regards to lifestyle recommendations to prevent or manage cardiometabolic risk and/or ASCVD
    8. Apply the evidence to prevent non-atherosclerotic cardiovascular disease such as atrial fibrillation and heart failure
      Pulmonary Hypertension and Venous Thromboembolic Disease
      Pulmonary Hypertension and Venous Thromboembolic Disease

    As a result of participating in the Pulmonary Hypertension and Venous Thromboembolic Disease Pathway sessions, learners will have an improved or reinforced ability to:

    1. Determine the most appropriate management strategies for acute pulmonary embolism
    2. Evaluate the diagnostic and therapeutic options for patients with pulmonary hypertension and coexistent left heart disease
    3. Review innovative translational discoveries and the potential for personalized medicine in PAH
    4. Describe key principals in managing patients with acute right ventricular failure
      Valvular Heart Disease
      Valvular Heart Disease

    As a result of participating in Valvular Heart Disease (VHD) Pathway sessions, learners will have an improved or reinforced ability to:

    1. Evaluate the evidence and controversies associated with recent changes to the classification framework and treatment thresholds outlined in VHD Guidelines
    2. Integrate understanding of etiology, mechanisms, natural history, and risk markers into the care of patients with right and left-sided valve disease
    3. Assess the role of advanced echo techniques, stress imaging, CT and CMR in characterizing native and prosthetic valvular disease and guiding management
    4. Determine a prudent management plan for patients with complex VHD whose care is not well-described by current VHD guidelines
    5. Incorporate the evidence on contemporary surgical, percutaneous, and device-based treatment options into clinical decision-making for patients with VHD
    6. Devise an exercise prescription for the patient with VHD
    7. Apply recent updates to guidelines and recommend best practices for valvular care to clinical practice
      Vascular Medicine
      Vascular Medicine

    As a result of participating in Vascular Medicine Pathway sessions, learners will have an improved or reinforced ability to:

    1. Evaluate the evidence associated with current controversies in the management of pulmonary embolism and deep venous thrombosis
    2. Incorporate recent clinical trial findings and evidence-based guideline recommendations into the treatment of patients with peripheral vascular disease
    3. Assess common vascular medicine complaints and synthesize the history, examination, and appropriate testing to diagnosis “can’t miss” vascular medicine disorders
    4. Utilize team-based approach to provide maximally effective Vascular Medicine care
    5. Recognize and effectively treat common vascular and thrombotic complications of cancer and cancer-directed therapy
    6. Use large registry analyses to describe geographic variation in peripheral artery disease diagnosis, treatment, and outcomes


    ACC Logo
    ACC.17 on Social Media:
    2017 American College of Cardiology Foundation. Visit
    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us